Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression

Apoptosis

Volumn 11, Issue 4, 2006, Pages 573-579

  Mikkelsen, M ^a   Sonder S U ^a   Nersting, J ^a   Bendtzen, K ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Anti inflammatory drugs; Apoptosis; Cytokines; Human mononuclear cells; Spironolactone; Spironolactone analogues (R203602; POD17 0175; POD07 0854; 1N 11448 and 1N 28123); Steroid hormones

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INTERLEUKIN-1; KINETICS; LEUKOCYTES, MONONUCLEAR; SPIRONOLACTONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646417666     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-4919-3     Document Type: Article

References (20)

1. Doggrell SA, Brown L. The spironolactone renaissance. Expert Opin Investig Drugs 2001; 10: 943-954.
2. Bendtzen K, Hansen PR, Rieneck K. Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 2003; 134: 151-158.
3. Hansen PR, Rieneck K, Bendtzen K. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol Lett 2004; 91: 87-91.
4. Gardiner P, Schrode K, Quinlan D, et al. Spironolactone metabolism: Steady-state serum levels of the sulfur-containing metabolites. J Clin Pharmacol 1989; 29: 342-347.
5. Jankowski A, Skorek-Jankowska A, Lamparczyk H. Simultaneous determination of spironolactone and its metabolites in human plasma. J Pharm Biomed Anal 1996; 14: 1359-1365.
6. Bohm I, Schild H. Apoptosis: The complex scenario for a silent cell death. Mol Imaging Biol 2003; 5: 2-14.
7. Okamoto K, Mizuno M, Nakahara N, et al. Process of apoptosis induced by TNF-alpha in murine fibroblast Ltk-cells: Continuous observation with video enhanced contrast microscopy. Apoptosis 2002; 7: 77-86.
8. Ravichandran KS. "Recruitment signals" from apoptotic cells: Invitation to a quiet meal. Cell 2003; 113: 817-820.
9. Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C. Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 1998; 3: 115-121.
10. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203-210.
11. Andersen LS, Petersen J, Bendtzen K. Production of interleukin (IL)-1beta, IL-1 receptor antagonist and IL-10 by blood mononuclear cells in chronic arthritis. Cytokine 2000; 12: 62-68.
12. Jonasdottir O, Petersen J, Bendtzen K. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis. APMIS 2001; 109: 781-786.
13. Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C. Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 1998; 3: 115-121.
14. Bendtzen K, Hansen PR, Rieneck K. Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 2003; 134: 151-158.
15. Hansen PR, Rieneck K, Bendtzen K. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol Lett 2004; 91: 87-91.
16. Rubartelli A, Cozzolino F, Talio M, Sitia R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 1990; 9: 1503-1510.
17. Hogquist KA, Unanue ER, Chaplin DD. Release of IL-1 from mononuclear phagocytes. J Immunol 1991; 147: 2181-2186.
18. Svenson M, Hansen MB, Kayser L, Rasmussen AK, Reimert CM, Bendtzen K. Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1. Cytokine 1992; 4: 125-133.
19. Wewers MD. IL-1beta: An endosomal exit. Proc Natl Acad Sci USA 2004; 101: 10241-10242.
20. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-8489.